Access
To read this story in full you will need to login or make a payment (see right).
News
Nature 444, 794-795 (14 December 2006) | doi:10.1038/444794a; Published online 13 December 2006
When good cholesterol turns bad
Helen Pearson
Last week's dramatic failure of a drug trial aimed at boosting 'good' cholesterol is bad news for Pfizer, the world's largest drug company. But will it also dash the hopes of those looking for a new way of preventing heart attacks?
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Crystal structure of CETP: new hopes for raising HDL to decrease risk of cardiovascular disease?Nature Structural & Molecular Biology News and Views (01 Feb 2007)
